mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice
Abstract The emergence of SARS-CoV-2 variants with defined mutations that enhance pathogenicity or facilitate immune evasion has resulted in a continual decline in the protective efficacy of existing vaccines. Therefore, there is a pressing need for a vaccine capable of combating future variants. In...
Saved in:
Main Authors: | Xiaoming Liang, Yuxia Yuan, Junbin Wang, Cong Tang, Yun Yang, Yanan Zhou, Hao Yang, Qing Huang, Wenhai Yu, Haixuan Wang, Yuhuan Yan, Dongdong Lin, Yanwen Li, Xuena Du, Longhai Yuan, Wenqi Quan, Daoju Wu, Shuaiyao Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-025-01066-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virus
by: Dongdong Lin, et al.
Published: (2025-01-01) -
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01) -
Clinically probable RBD is an early predictor of malignant non-motor Parkinson’s disease phenotypes
by: Alfonso Enrique Martinez-Nunez, et al.
Published: (2025-01-01) -
A SARS‐CoV‐2 EG.5 mRNA vaccine induces a broad‐spectrum immune response in mice
by: Hongyu Wang, et al.
Published: (2025-01-01) -
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
by: Denis N. Kisakov, et al.
Published: (2025-01-01)